Skip to content
MarketScale
‹ Back to IndustriesHealthcare

CurveBeam Connect: An Insider Look at the New CurveBeam Cloud Technology

Despite all of the challenges that the COVID-19 pandemic has brought us over the past year, it’s also shown us a silver lining: When it comes to the systems in our society, there’s so much that we can still improve on. Take the medical field, for example. So many of us have waited weeks or…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
CurveBeam Connect: An Insider Look at the New CurveBeam Cloud Technology

Despite all of the challenges that the COVID-19 pandemic has brought us over the past year, it’s also shown us a silver lining: When it comes to the systems in our society, there’s so much that we can still improve on.

Take the medical field, for example. So many of us have waited weeks or months to get a medical procedure done, shuttling back and forth between labs and doctors’ offices, sometimes even for the smallest things.

However, a new development from CurveBeam is set to change all that.

On this episode of the CurveBeam Connect podcast, host and CurveBeam Marketing Director Vinti Singh met up with Turner Dean and Stuti Singh to talk about CurveBeam Cloud, the newest offering in the company’s suite of products. Dean, CurveBeam’s Vice President of Sales, and Singh, Senior Systems Engineer, have worked tirelessly to develop this product and have much to share about their latest development.

“We saw the opportunity to create an ecosystem where we could collaborate and solve a number of issues that our clients have had over the years in terms of managing their data sets and their information,” Dean said.

With the implementation of this new, cloud-based platform, “we see opportunity to eliminate time, expense, mistakes and errors, and make the process a lot more efficient and cost-effective,” he continued.

For the latest news and diagnostic imaging thought leadership from CurveBeam, as well as updates when the CurveBeam Cloud platform launches, visit our website at curvebeam.com.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health venture funding reached $7.4B in the first half of 2026, with significant investments in AI agent platforms and chronic care tools. Mega-deals of over $100 million were a key driver of the funding surge.

  • 01Digital health VC funding hit $7.4 billion in the first half of 2026.
  • 02Mega-deals in AI agent platforms and chronic care tools exceeded $100 million.
  • 03AI, chronic care, and workforce tools dominate digital health investments.

Aug 4, 2026

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

The Centers for Medicare & Medicaid Services (CMS) has established the Office of Health Technology and Products to integrate AI, interoperability, and digital strategies. This new office aims to enhance efficiency across Medicare, Medicaid, and CHIP programs. By centralizing these efforts, CMS seeks to improve healthcare delivery and outcomes.

  • 01The CMS has launched a new office focusing on AI and interoperability.
  • 02The Office of Health Technology and Products will support Medicare, Medicaid, and CHIP programs.
  • 03Centralizing digital strategies aims to improve healthcare delivery and outcomes.

Aug 1, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512